Company "Camelyn" is a scientific-pharmaceutical company that is dedicated to identifying and developing immunomodulatory activity, antitumoral, antibacterial, and antivirus treatment products. as well as identifying and developing biologically active compounds for use in the food industry and cosmetology. 

The company concentrates on the use of the substance "Camelyn M" obtained from Georgian organic honey and currently produces five types of preparations based on it.

"Camelyn M" was created by the famous Georgian doctor and scientist Benedikte Maglakelidze, using organic methods, by extracting active substances from honey.
Research on the "Camelyn" was conducted not only in Georgia but also in the best scientific and clinical centers of the world. In the leading scientific and clinical centers of Quebec, Montreal, Illinois, Oregon, Bern, Germany, England, Rio de Janeiro, and Delhi, it has been proven that "Camelyn" is a drug with great potential for the treatment of antibiotic-resistant bacteria, viruses, and fungal diseases, as well as being especially effective with the fight against cancer.

The company operates not only in the Georgian market but also tries to enter the international arena, in America it founded its subsidiary company “Camelyn U.S. Incorporation” and in Greece the company “Camelyn International”, which will be engaged in the sale of products created on the basis of "Camelyn" in the world market.

For viewing the products, please visit the link